Amarin's Patent Infringement Lawsuit, And Other News: The Good, Bad, And Ugly Of BiopharmaSeeking Alpha • 01/02/20
Has Amarin Corporation (AMRN) Outpaced Other Medical Stocks This Year?Zacks Investment Research • 12/27/19
After Amarin Snags Vascepa Label Expansion, Analyst Says Biopharma An Attractive M&A TargetBenzinga • 12/16/19
Amarin Receives FDA Approval of VASCEPA® (icosapent ethyl) to Reduce Cardiovascular RiskGlobeNewsWire • 12/13/19
Is Amarin Corporation (AMRN) Stock Outpacing Its Medical Peers This Year?Zacks Investment Research • 12/11/19